Can Biogen Keep the Beat Streak Alive This Earnings Season?

• click to rate

  Posted by Two Blokes Apr 24 - Filed in Stock - 2 views
  
  In the first quarter, lower sales of BIIB's multiple sclerosis drugs are likely to have been offset by revenues from new drugs.